Gene · 6752
Papers3,968
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,968
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Paltusotine: First Approval. | Drugs | 2026 | 41296264 | PubTator, text mining | PubMed |
| A Case of Grade 3 Gastric Neuroendocrine Tumor with Glandular Formation: Diagnosis and Differentiation from Gastric Mixed Neuroendocrine-Non-Neuroendocrine Neoplasm. | J Nippon Med Sch | 2026 | 41242723 | PubTator, text mining | PubMed |
| Primary sporadic intracranial DICER1 mutant sarcoma with SSTR2 positivity in an adult patient mimicking anaplastic meningioma. | J Neuropathol Exp Neurol | 2026 | 41217766 | PubTator, text mining | PubMed |
| Rapid and Sustained Response of Biochemically Uncontrolled Acromegaly to Once-daily Oral Paltusotine Treatment. | J Clin Endocrinol Metab | 2026 | 41128642 | PubTator, text mining | PubMed |
| Gastrointestinal Neuroendocrine Neoplasms in Children and Adolescents: Data from the German MET Studies (1997-2024). | Neuroendocrinology | 2026 | 40996947 | PubTator, text mining | PubMed |
| Treatment with radionuclide-labeled peptides in refractory meningiomas: Updated review and clinical perspectives. | Rev Esp Med Nucl Imagen Mol (Engl Ed) | 2026 | 40915497 | PubTator, text mining | PubMed |
| Synthesis, preclinical evaluation, and clinical translation of [68Ga]Ga-Asp2-JR11, a SSTR2 antagonist for PET imaging of neuroendocrine neoplasms. | Eur J Nucl Med Mol Imaging | 2026 | 40883440 | PubTator, text mining | PubMed |
| [177Lu]Lu-DOTATATE for Recurrent Meningioma (LUMEN-1, EORTC-2334-BTG): Study Protocol for a Randomized Phase II Trial. | J Nucl Med | 2026 | 40774695 | PubTator, text mining | PubMed |
| A Rare Case of Retroperitoneal Teratoma Mimicking Paraganglioma on Multimodality Imaging. | Clin Nucl Med | 2026 | 40705524 | PubTator, text mining | PubMed |
| New approaches in nuclear medicine theranostics. | Br J Radiol | 2026 | 40580450 | PubTator, text mining | PubMed |
| Cranial Reconstruction for Infiltrative Meningioma Using 68 Ga-DOTATATE Positron Emission Tomography/Computed Tomography and Individual Patient Solutions CaseDesigner®: A Case Series. | Oper Neurosurg | 2026 | 40314447 | PubTator, text mining | PubMed |
| Adrenal mixed corticomedullary tumors: report of a case with molecular characterization and systematic review. | Virchows Arch | 2026 | 40175770 | PubTator, text mining | PubMed |
| Meningeal metastatic tumor with bone destruction from follicular thyroid carcinoma: a case report and literature review. | Front Surg | 2025 | 41568262 | PubTator, text mining | PubMed |
| Somatostatin receptor PET-guided treatment and artificial intelligence applications in meningioma: a comprehensive review. | Am J Nucl Med Mol Imaging | 2025 | 41567833 | PubTator, text mining | PubMed |
| Extracranial Spread of Meningiomas: Molecular Determinants, Diagnostic Pathways, and Lessons From Three Thoracic Metastases. | Cureus | 2025 | 41552249 | PubTator, text mining | PubMed |
| Expanding the therapeutic horizon of 177Lu-DOTATATE: a review of current evidence. | Nagoya J Med Sci | 2025 | 41550194 | PubTator, text mining | PubMed |
| Extra-Axial Dural-based Cavernous Hemangioma of Skull Base in a 15-year-old Male: A tale of complex case with favorable outcome. | Pak J Med Sci | 2025 | 41522408 | PubTator, text mining | PubMed |
| Long-term outcomes of active surveillance after DOTATATE PET/MRI-confirmed gross total resection in WHO grade 2 meningioma. | Neurooncol Adv | 2025 | 41497451 | PubTator, text mining | PubMed |
| Evaluation of folate receptor-alpha and other surface markers as potential targets for radionuclide therapy of ovarian cancer. | EJNMMI Res | 2025 | 41466165 | PubTator, text mining | PubMed |
| Distinguishing neuroendocrine tumor grade 3 from neuroendocrine carcinoma in gastroenteropancreatic high-grade neoplasms. | Endocr Oncol | 2025 | 41450443 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6752/papers?page=7